title: Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis.
authors.forename: Lorena
authors.initials: L
authors.lastname: Huelves
authors.forename: Matilde
authors.initials: M
authors.lastname: Gracia
authors.forename: Gema
authors.initials: G
authors.lastname: Del Prado
authors.forename: Violeta
authors.initials: V
authors.lastname: Rodríguez-Cerrato
authors.forename: Carmina
authors.initials: C
authors.lastname: Martínez-Marín
authors.forename: Carmen
authors.initials: C
authors.lastname: Ponte
authors.forename: Francisco
authors.initials: F
authors.lastname: Soriano
authors.forename: Pilar
authors.initials: P
authors.lastname: Coronel
authors.forename: Mercedes
authors.initials: M
authors.lastname: Gimeno
authors.forename: Jorge
authors.initials: J
authors.lastname: Blanco
mesh_terms: D018784:Abdominal Abscess / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001442:Bacteroides Infections / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality; D001441:Bacteroides fragilis / Q000187:drug effects*; D002513:Cephamycins / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology / Q000401:mortality; D006801:Humans; D051379:Mice; D018805:Sepsis / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002513:Cephamycins; D019980:Amoxicillin-Potassium Clavulanate Combination; C046079:cefminox